HomeHRMY • NASDAQ
Harmony Biosciences Holdings Inc
$32.94
3.10%
-1.05 Today
Nov 19, 12:42:29 PM UTC-5 · USD · NASDAQ · Disclaimer
Financials
Income Statement
0100M200M
Revenue
Net Income
Revenue
Net income
(USD)Sep 2025Y/Y change
Revenue
239.46M28.71%
Operating expense
114.32M40.18%
Net income
50.87M10.35%
Net profit margin
21.24-14.29%
Earnings per share
1.084.85%
EBITDA
71.46M5.58%
Effective tax rate
24.63%
0500M1B
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Sep 2025Y/Y change
Cash and short-term investments
672.58M63.85%
Total assets
1.21B30.18%
Total liabilities
373.10M12.60%
Total equity
835.12M
Shares outstanding
57.60M
Price to book
2.34
Return on assets
14.14%
Return on capital
16.78%
050M100M
Net Change in Cash
Net change in cash
(USD)Sep 2025Y/Y change
Net income
50.87M10.35%
Cash from operations
108.73M54.23%
Cash from investing
-4.79M-742.82%
Cash from financing
-3.00M-154.98%
Net change in cash
100.95M44.07%
Free cash flow
57.45M-15.39%
StockUS listed security
Previous close
$33.99
Day range
$32.77 - $34.04
Year range
$25.52 - $40.93
Market cap
1.91B USD
Avg Volume
889.13K
P/E ratio
10.37
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Employees
268
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Finance
Search
Clear search
Close search
Main menu
Google apps